Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Hepatitis B virions (orange coloured)

© CDC/Dr. Erskine Palmer

© CDC/Dr. Erskine Palmer
Mar 28 2018

Hepatitis B: Cure is the goal

Worldwide, approximately 260 million people suffer from chronic hepatitis B which is currently incurable. However, there is now a shimmer of hope on the horizon as scientists at the DZIF have

CERMEL Director Bertrand Lell

© Universitätsklinikum Tübingen

© Universitätsklinikum Tübingen
Feb 16 2018

New process allows tailor-made malaria research

Scientists at the Institute of Tropical Medicine of the University of Tübingen, the German Center for Infection Research (DZIF), and of Sanaria Inc. have developed an infection system that allows

Every step is precisely monitored in clinical trials.

© MedizinFoto Köln

© MedizinFoto Köln
Jan 17 2018

Improving pneumonia protection for dialysis patients

The first joint study to be conducted across all twelve clinical trial units at the German Center for Infection Research (DZIF) has been initiated. The aim of the study is to improve vaccine

Biofilm of a clinical isolate of Pseudomonas aeruginosa stained with fluorescent dyes

© Twincore/Janne Thöming

© Twincore/Janne Thöming
Dec 7 2017

Detection of bacterial biofilms using covalent lectin binders

DZIF researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) produced a molecule that provides a way to visualise Pseudomonas infection. The scientists published their

Blackbird infected by the Usutu virus

© Jutta Böhm-Wacker

© Jutta Böhm-Wacker
Nov 22 2017

Usutu virus decreases the population of common blackbirds in the outbreak region

The Usutu virus endangers birds and has been circulating in Germany since 2010. However, estimating its impact on bird populations in the outbreak region has hardly been possible up to now. For the

Fazenda Grande do Retiro: district in Salvador, Brazil

© Ianei Carneiro

© Ianei Carneiro
Nov 15 2017

“The Brazilian Zika outbreak could end soon”

Scientists have elucidated the Zika burden in a Brazilian metropolis. Their data indicate: the outbreak may be coming to an end and further outbreaks in the region seem unlikely. The study has also

Helicobacter pylori

© HZI/ M. Rohde

© HZI/ M. Rohde
Oct 24 2017

Helicobacter pylori: Dodging the bullet

Helicobacter pylori is a widespread bacterial pathogen that infects the lining of the stomach, where it can cause ulcers and even cancer. As a new study shows, its genetic variability complicates

DZIF coordinator Prof P. Kremsner

© DZIF/scienceRELATIONS

© DZIF/scienceRELATIONS
Oct 9 2017

Ebola vaccine can now be used on children

An international team of researchers has successfully tested a vaccine against the Ebola virus: The medical experts have established a dose which could offer successful protection against the Ebola

Electron microscope image of Ebola viruses

© NIAID

© NIAID
Aug 30 2017

Ebola: Early immune response provides insight into vaccination

The latest outbreaks of emerging, dangerous pathogens, such as Ebola, MERS-CoV or Zika, emphasise the importance of the rapid development of effective vaccines. However, being able to predict the

Maximilian Muenchhoff
Jun 20 2017

Maximilian Muenchhoff has been honoured with the HIV/AIDS Research Award

Some HIV-infected – and untreated children – who do not develop AIDS, control the virus in a different way from the few infected adults who remain disease-free. Dr Maximilian Muenchhoff, DZIF

Pagination

Previous page ‹‹
Seite 34 Seite 35 Seite 36 Seite 37 Current page 38 Seite 39 Seite 40 Seite 41 Seite 42
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states